Results for keyword: clanotech

Top keyword related from Google/Bing/Yahoo of clanotech

clanotechclanotech abclantech
clinotechclinotech groupclinotech testing
clantech motion detetionclantech njclantech inc
clantech pv-100aclantech motion detection technologyclantech steve daley
clinotech inc hires a psychologistcanotechcanotech winnipeg
canotech constructioncanotech malawicanotech consultants
cyanotechclan techiecanotech consultants ltd
clan techie star warscyanotech corporationclan techie eyes

Load more

Top URL related to clanotech

1. Text link: Clanotech AB

Domain: www.clanotech.se

Link: http://www.clanotech.se/

Description: Clanotech is active in ophthalmology. Clanotech’s development strategy spans from indications with orphan drug opportunities such as developing safe and target specific anti-scarring treatment in glaucoma surgery techniques to therapeutic areas with high commercial potential as wet Age Related Macular Degeneration, proliferative diabetic retinopathy, proliferative vitreoretinopathy ...

2. Text link: Clanotech AB / Science

Domain: clanotech.se

Link: http://clanotech.se/science.asp

Description: Clanotech's solution and competitive advantages Clanotech's alpha5beta1-integrin antagonist has shown to have anti-angiogenic, anti-fibrotic and anti-inflammatory properties needed for the optimal balance in the wound healing and angiogenesis processes.

3. Text link: Clanotech Company Profile: Valuation & Investors | PitchBook

Domain: pitchbook.com

Link: https://pitchbook.com/profiles/company/61140-07

Description: Information on valuation, funding, cap tables, investors, and executives for Clanotech. Use the PitchBook Platform to explore the full profile.

4. Text link: Clanotech AB Receives Orphan Drug Designation In The U.S ...

Domain: www.biospace.com

Link: https://www.biospace.com/article/releases/clanotech-ab-receives-orphan-drug-designation-in-the-u-s-/

Description: STOCKHOLM - March 27, 2015. Clanotech AB announced today that its candidate drug CLT-28643 has received orphan drug designation by the U.S. Food and Drug Administration (FDA) for prevention of scarring after glaucoma surgery.

5. Text link: Patrizia Caldirola - CEO - Clanotech | LinkedIn

Domain: www.linkedin.com

Link: https://www.linkedin.com/in/patrizia-caldirola-3b1024a

Description: Patrizia Caldirola Clanotech Sverige 227 kontakter. Gå med för att skapa kontakt. Clanotech. Free University. Info. II have approximately 25 years of experience of the pharmaceutical industry ...

6. Text link: ClanoTech AB | LinkedIn

Domain: www.linkedin.com

Link: https://www.linkedin.com/company/clanotech-ab

Description: Learn about working at ClanoTech AB. Join LinkedIn today for free. See who you know at ClanoTech AB, leverage your professional network, and get hired.

7. Text link: Clanotech AB | VentureRadar

Domain: www.ventureradar.com

Link: https://www.ventureradar.com/organisation/Clanotech%20AB/ad253bbf-e4e6-4283-944b-0716b0443571

Description: Clanotech is developing small molecules for alpha5beta1-integrin inhibition for treatment of diseases of the eye. ... Find out more about Clanotech AB, Cancer Therapeutics and Healthtech and Life Sciences.

8. Text link: Yihai Cao, Director at Clanotech AB - Relationship Science

Domain: relationshipscience.com

Link: https://relationshipscience.com/person/yihai-cao-4490970

Description: ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells.

9. Text link: Clanotech AB Receives Orphan Drug Designation In The EU ...

Domain: www.biospace.com

Link: https://www.biospace.com/article/releases/clanotech-ab-receives-orphan-drug-designation-in-the-eu-/

Description: Clanotech is a Swedish biotech company active in ophthalmology. Clanotech development strategy spans from niche indications with orphan drug opportunities such as developing safe and target specific anti-scarring treatment in glaucoma surgery techniques to therapeutic areas with high commercial potential as wet Age Related Macular Degeneration.

10. Text link: EU/03/14/1279 | European Medicines Agency

Domain: www.ema.europa.eu

Link: https://www.ema.europa.eu/en/ema-redirect?redirect_type=jsp&curl=pages/medicines/human/orphans/2014/07/human_orphan_001361.jsp

Description: On 4 June 2014, orphan designation (EU/03/14/1279) was granted by the European Commission to Clanotech AB, Sweden, for 4-(4-methoxy-phenylamino)-6-methylcarbamyl-quinoline-3-carboxylic acid for the prevention of scarring post glaucoma filtration surgery.

Load more (10)